Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

Inhibitors bind to enzymes and decrease or prevent their biological activity. They may bind in an enzymeÆs active site or at some other site on the protein. The inhibitorÆs activity can be reversible or irreversible. Reversible inhibitors bind non ûcovalently to an enzyme or enzyme-substrate complex. Irreversible inhibitors typically form covalent linkages to an enzyme, changing it chemically so it can no longer catalyze a reaction. Signal transduction pathways are altered in disease systems and are the target for novel drug therapy. Alfa Aesar supplies a wide range of products that act as inhibitors for various signal transduction pathways. These products can be used for therapeutic strategies by inhibiting signaling pathways of interest.

  • 10058-F4
  • 1,2,3,4,5,6-Hexabromocyclohexane
  • 12-Methoxydodecanoic acid, 98%
  • 1,3-Bis(4-bromophenyl)-5-phenyl-2,4-imidazolidinedione
  • 1,3-Diethyl-5,6-diaminouracil
  • 13(S)-Hydroxyoctadeca-9Z,11E-dienoic acid, 98%, 90-100 µg/mL in ethanol
  • 17-DMAG, 98%
  • 1,8,9-Trihydroxyanthracene, 97%
  • 1-Aminobenzotriazole, 97%
  • 1-Hydrazinophthalazine hydrochloride, 98%
  • 2-(3-(2,3-Dichlorophenoxy)propylamino)ethanol hydrochloride
  • 2-(4,5,6,7-Tetraiodo-1,3-dioxoisoindolin-2-yl)acetic acid
  • 2,4,6-Trimethyl-N-[2-(trifluoromethyl)phenyl]benzenesulfonamide
  • 2,4,6-Trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide
  • 2'-Amino-3'-methoxyflavone, 99%
  • 2-Aminopurine, 98%
  • 2-Chloro-11-(1-piperazinyl)dibenzo[b,f]-1,4-oxazepine, 98%
  • 2-Chloro-5-nitro-N-(4-pyridyl)benzamide
  • 2-Fluoro-alpha-methyl-4-biphenylacetic acid, 99%
  • 2-Methyl-5-hydroxytryptamine hydrochloride, 97%
  • 3,4-Dihydroxycinnamic acid, predominantly trans, 98+%
  • 3,4-Dihydroxy-L-phenylalanine, 98+%
  • 3-Bromo-7-nitroindazole, 98+%
  • 3-Isobutyl-1-methylxanthine
  • 4',5,7-Trihydroxyflavone, 97%
  • 4-(7-Chloro-4-quinolinylamino)-2-(diethylaminomethyl)phenol dihydrochloride dihydrate, 98%
  • 4-Amino-1,8-naphthalimide, 95%
  • 4-Dimethylamino-N-(6-hydroxyamino-6-oxohexyl)benzamide
  • 4-Hydroxy-1H-pyrazolo[3,4-d]pyrimidine, 98%
  • 4-Hydroxybenzylidenemalononitrile, 98%
  • 4'-Hydroxydiclofenac
  • 4-Isobutyl-alpha-methylphenylacetic acid, 99%
  • (4-Methoxybenzylidene)malononitrile, 99%
  • 4-Nitrophenylphosphorylcholine
  • 4-Phenylchalcone Oxide, 99%
  • 5-[3-(Dimethylamino)propylidene]dibenzosuberane hydrochloride, 98%
  • 5,6-Dichlorobenzimidazole riboside, 98%
  • 5,8,11,14-Eicosatetraynoic acid
  • 5Z-7-Oxozeaenol
    5Z-7-oxozeaenol acts as an irreversible ATP-competitive inhibitor of ERK2 (IC<sub>50</sub> = 80 nM). It also inhibits TAK1 (MEKK7), MKK7, and MEK1, which all contain a common cysteine residue in the ATP-binding site. 5Z-7-oxozeaenol does not inhibit other MAP kinases.
  • 6-Bromoindirubin-3'-oxime, 97%
  • 6-Hydroxyflavone, 98%
  • 6-Methoxy-2-naphthylacetic acid, 99%
  • 7,7-Dimethyleicosadienoic acid, 99%
  • 7,8-Dichloro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
  • 7-Hydroxycoumarin glucuronide sodium salt, 97%
  • 7-Methyl lumazine
  • A-7 hydrochloride
  • Acarbose, 95%
  • Aceclofenac, 99%
  • Acetohydroxamic acid, 98%

Chemicals

Life Science

Metals & Materials

Catalysts

Analytical & Labware